Compass Ion Advisors
NVS icon

Compass Ion Advisors’s Novartis NVS Stock Holding History

Compass Ion Advisors’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$365K Hold
2,560
– – 0.03% 219
2026
Q2 		$401K Sell
2,560
-31
-1% -$4.65K 0.03% 211
2026
Q1 		$396K Buy
2,591
+31
+1% +$4.75K 0.04% 200
2025
Q4 		$353K Sell
2,560
-164
-6% -$21.5K 0.03% 204
2025
Q3 		$349K Buy
2,724
+149
+6% +$18.2K 0.03% 207
2025
Q2 		$312K Hold
2,575
– – 0.03% 207
2025
Q1 		$287K Hold
2,575
– – 0.03% 213
2024
Q4 		$251K Sell
2,575
-82
-3% -$8.74K 0.03% 228
2024
Q3 		$306K Sell
2,657
-47
-2% -$5.33K 0.04% 205
2024
Q2 		$262K Hold
2,704
– – 0.04% 199
2024
Q1 		$262K Hold
2,704
– – 0.04% 199
2023
Q4 		$273K Sell
2,704
-233
-8% -$22.5K 0.04% 197
2023
Q3 		$299K Buy
+2,937
New +$298K 0.05% 186
2020
Q4 		– Sell
-2,768
Closed -$241K – 90
2020
Q3 		$241K Buy
+2,768
New +$240K 0.15% 70

Other funds holding NVS

Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Todd Asset Management
Todd Asset Management Louisville, Kentucky $5.51B AUM 33.77% 1-Year Est. Return
Midwest Trust
Midwest Trust Overland Park, Kansas $8.99B AUM 21.14% 1-Year Est. Return
Miller Howard Investments
Miller Howard Investments Kingston, New York $3.72B AUM 18.2% 1-Year Est. Return
Oppenheimer Asset Management
Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
Godsey & Gibb Inc
Godsey & Gibb Inc Richmond, Virginia $1.21B AUM 18.94% 1-Year Est. Return
D.A. Davidson & Co
D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return
Grandfield & Dodd
Grandfield & Dodd New York $1.87B AUM 27.26% 1-Year Est. Return

Compass Ion Advisors's NVS Position: Q3 2026 in Review

Compass Ion Advisors held its Novartis (NVS) position steady in Q3 2026 at 2,560 shares worth $365K. The position accounts for 0.03% of the portfolio, ranked #219.

Compass Ion Advisors first reported a position in NVS in Q3 2020 and has held it in 14 quarters since. The position peaked at $401K in Q2 2026. 684 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Compass Ion Advisors held 2,560 shares of Novartis worth $365K as of Q3 2026.
  • Compass Ion Advisors left its Novartis share count unchanged in Q3 2026.
  • Novartis made up 0.03% of Compass Ion Advisors's portfolio in Q3 2026, its #219 holding.
  • Compass Ion Advisors first reported a position in Novartis in Q3 2020 and has held it in 14 quarters since.
  • Compass Ion Advisors's Novartis position peaked at $401K in Q2 2026.
  • 684 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Compass Ion Advisors's 13F filing for Q3 2026, filed 23 Oct 2026.